Furthermore, Spear et al. reported that cucurbitacin D and goyazensolide exhibit anti-proliferative activity in NF2-deficient schwannoma and meningioma cells, though neither has been tested in primary VS cells or in in vivo models21. This evidence concerns the gene NF2 and schwannoma.